CRYSTALLINE FORMS OF SODIUM 4-{9-CHLORO-7-(2-FLUORO-6-METHOXYPHENYL)-5H-PYRIMIDO5,4-D2BENZAZEPIN-2YLAMINO}-2-METHOXYBENZOATE

摘要

The present invention is directed to a compound of formula (Z): or a crystalline form thereof, or a solvate thereof; to a solid pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (I), or a crystalline form thereof, or a solvate thereof, and at least one pharmaceutically acceptable carrier or diluent, and to the use of a compound of formula (J), or a crystalline form thereof, or a solvate thereof, for treating a patient suffering from, or subject to, a disease, disorder, or condition mediated by Aurora kinase, and methods related thereto.